货号:GS40773
Vamikibart (RG6179) is a humanized IgG2 kappa monoclonal antibody targeting interleukin-6 (IL-6), a pro-inflammatory cytokine. It binds to and neutralizes IL-6, preventing its interaction with both soluble and membrane-bound IL-6 receptors, thereby inhibiting downstream JAK/STAT signaling. It is being developed for the treatment of autoimmune and inflammatory diseases, such as rheumatoid arthritis and systemic lupus erythematosus.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯